Nutriband Inc NTRB.OQ NTRB.O is expected to report resultson April 28 (estimated) for the period ending January 31 2025
The Orlando Florida-based company is expected to report revenue of $710 thousand, according to the estimate from one analyst, based on LSEG data.
LSEG's mean analyst estimate for Nutriband Inc is for a loss of 12 cents per share.
The one available analyst rating on the shares is "buy".
The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "Buy".
Wall Street's median 12-month price target for Nutriband Inc is $13.00, above its last closing price of $5.32.
This summary was machine generated April 25 at 21:37 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)